Summary
Latest filing:
Neil F. McFarlane is President and CEO, Director of ZEVRA THERAPEUTICS, INC. (ZVRA). 3 SEC Form 4 filings on record going back to 2025, most recently on 10 February 2026. Most recent open-market trade: sold $125K of ZVRA on 10 February 2026. Lifetime open-market sales: $1.19M.
Recent Transactions
6Every recent SEC Form 4 transaction Neil F. McFarlane has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil F. McFarlane files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rahsaan Thompson - $969K of ZVRA open-market activity in the last 12 months
- Corey Michael Watton - $138K of ZVRA open-market activity in the last 12 months
- Joshua Schafer - $126K of ZVRA open-market activity in the last 12 months
- Timothy J. Sangiovanni - $43K of ZVRA open-market activity in the last 12 months
- Adrian W. Quartel - $40K of ZVRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Neil F. McFarlane?
Neil F. McFarlane is a corporate insider, tracked as President and CEO, Director of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Neil F. McFarlane last file a Form 4?
The most recent primary Form 4 on record is dated 10 February 2026, one of 3 filings going back to 2025.
Has Neil F. McFarlane been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.19M) across all tracked filings.
Where can I see all of Neil F. McFarlane's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Neil F. McFarlane and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
